(Q54511531)

30 May 2018

title

Saliva Interleukin-6 in patients with inflammatory bowel disease. (English)

1 reference

30 May 2018

inflammatory bowel diseases

main subject

0 references

0 references

1 reference

Aneta Aleksandra Nielsen

1

1 reference

30 May 2018

Jens Nederby Nielsen

2

1 reference

30 May 2018

Anne Schmedes

3

1 reference

30 May 2018

Ivan Brandslund

4

1 reference

30 May 2018

Henrik Hey

5

1 reference

30 May 2018

publication date

1 December 2005

1 reference

30 May 2018

Scandinavian Journal of Gastroenterology

published in

1 reference

30 May 2018

volume

40

1 reference

30 May 2018

issue

12

1 reference

30 May 2018

page(s)

1444-1448

1 reference

30 May 2018

Elevated cell-associated levels of interleukin 1beta and interleukin 6 in inflamed mucosa of inflammatory bowel disease.

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00365520510023774

Interrelations between interleukin-6, interleukin-1 beta, plasma C-reactive protein values, and in vitro C-reactive protein generation in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520510023774

Interleukin 6 and its receptor: ten years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520510023774

Spironolactone inhibits production of proinflammatory cytokines, including tumour necrosis factor-alpha and interferon-gamma, and has potential in the treatment of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520510023774

10.1080/00365520510023774

21 January 2018

Identifiers

DOI

1 reference

30 May 2018

PubMed ID

16316893

1 reference

30 May 2018